Dr. Liming Zhu 朱利明
Chief Physician
Department of Medical Oncology for Colorectal Cancer, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of digestive system malignancies, lung cancer, and tumors of unknown primary origin. Focuses on individualized comprehensive therapy using chemotherapy, immunotherapy, and targeted therapy.
Dr. Zhu is Chief Physician and Deputy Director of the Hospital Office at Zhejiang Cancer Hospital. A graduate of Zhejiang University School of Medicine, Dr. Zhu has practiced since 1999. Research interests include dendritic cell vaccines and hyperthermia for non-small cell lung cancer. Dr. Zhu participated in over ten multi-center clinical trials and co-authored three oncology monographs.
Name order: in Chinese the family name comes first (Zhu Liming). Papers usually list the name as Liming Zhu or Zhu L.
Selected publications
17 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMC Health Serv Res, 2026 (senior author): Development and psychometric validation of the hospital Security Personnel Narrative Competency Scale (HSPNCS). PubMed 42745274
- Biosci Rep, 2020 (senior author): APC gene 3'UTR SNPs and interactions with environmental factors are correlated with risk of colorectal cancer in Chinese Han population. PubMed 32159210
- Oncotarget, 2016 (senior author): Correlation of neuroendocrine features with prognosis of non-small cell lung cancer. PubMed 27687592
- J Cancer Res Ther, 2014 (first author): High levels of D-dimer correlated with disease status and poor prognosis of inoperable metastatic colorectal cancer patients treated with bevacizumab. PubMed 25693928
- Med Oncol, 2014 (senior author): Association of FoxP3 rs3761548 polymorphism with susceptibility to colorectal cancer in the Chinese population. PubMed 25416053
- Asian Pac J Cancer Prev, 2014 (first author): Efficacy and safety of bevacizumab in Chinese patients with metastatic colorectal cancer. PubMed 25169487
- J Res Med Sci, 2013 (first author): Prostate adenocarcinoma with negative immunohistochemical stain of prostate-specific antigen presenting with cervical mass: A case report. PubMed 24381627
- Med Oncol, 2012 (senior author): The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis. PubMed 21630055
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion